Cargando…

TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma

Rossi E, Villanacci V, Bassotti G, Donato F, Festa A, Cengia G, Grisanti S & Cestari R (2010) Histopathology57, 81–89 TOPOIIα and HER-2/neu overexpression/amplification in Barrett’s oesophagus, dysplasia and adenocarcinoma AIMS: Topoisomerase IIα (TOPOIIα) and HER-2/neu are chromosome 17q genes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rossi, Elisa, Villanacci, Vincenzo, Bassotti, Gabrio, Donato, Francesco, Festa, Andrea, Cengia, Gianpaolo, Grisanti, Salvatore, Cestari, Renzo
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Ltd 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2916224/ https://www.ncbi.nlm.nih.gov/pubmed/20557373 http://dx.doi.org/10.1111/j.1365-2559.2010.03580.x

Ejemplares similares

HER-2 overexpression/amplification in Barrett’s oesophagus predicts early transition from dysplasia to adenocarcinoma: a clinico-pathologic study
por: Rossi, Elisa, et al.
Publicado: (2009)

Optical Biopsy of Dysplasia in Barrett’s Oesophagus Assisted by Artificial Intelligence
por: van der Laan, Jouke J. H., et al.
Publicado: (2023)

Update on endoscopic treatment of Barrett’s oesophagus and Barrett’s oesophagus–related neoplasia
por: Pech, Oliver, et al.
Publicado: (2020)

The utility of P53 immunohistochemistry in the diagnosis of Barrett's oesophagus with indefinite for dysplasia
por: Januszewicz, Wladyslaw, et al.
Publicado: (2022)

Barrett's oesophagus and adenocarcinoma
por: Caygill, Christine PJ, et al.
Publicado: (2004)

Management of Barrett's oesophagus
por: Mannath, Jayan, et al.
Publicado: (2009)

Diagnosis and management of Barrett’s oesophagus
por: Jankowski, Janusz, et al.
Publicado: (2010)

The metaplastic mosaic of Barrett’s oesophagus
por: Biswas, Sujata, et al.
Publicado: (2018)

Barrett’s oesophagus: Current controversies
por: Amadi, Chidi, et al.
Publicado: (2017)

Monitoring the premalignant potential of Barrett's oesophagus'
por: Graham, David, et al.
Publicado: (2016)

Detecting Barrett oesophagus using Cytosponge
por: Hindson, Jordan
Publicado: (2020)

Screening for Barrett's oesophagus: is now the time?
por: Hanada, Yuri, et al.
Publicado: (2020)

Screening for Barrett’s Oesophagus: Are We Ready for it?
por: Yusuf, Aisha, et al.
Publicado: (2021)

Comparison of nuclear texture analysis and image cytometric DNA analysis for the assessment of dysplasia in Barrett's oesophagus
por: Dunn, J M, et al.
Publicado: (2011)

The combination of autofluorescence endoscopy and molecular biomarkers is a novel diagnostic tool for dysplasia in Barrett's oesophagus
por: di Pietro, Massimiliano, et al.
Publicado: (2015)

Prevalent low-grade dysplasia: the strongest predictor of malignant progression in Barrett's columnar-lined oesophagus
por: Moyes, Lisa H, et al.
Publicado: (2016)

Revised British Society of Gastroenterology recommendation on the diagnosis and management of Barrett's oesophagus with low-grade dysplasia
por: di Pietro, Massimiliano, et al.
Publicado: (2018)

Novel oral-targeted therapies for mucosal healing in ulcerative colitis
por: Antonelli, Elisabetta, et al.
Publicado: (2018)

Exploring Pharmacological Treatments for Chronic Idiopathic Constipation in Adults: A Look Back to the Future
por: Bassotti, Gabrio, et al.
Publicado: (2023)

What Is “Cold” and What Is “Hot” in Mucosal Ablation for Barrett’s Oesophagus-Related Dysplasia: A Practical Guide
por: Spadaccini, Marco, et al.
Publicado: (2023)

Metallothionein in human oesophagus, Barrett's epithelium and adenocarcinoma
por: Coyle, P, et al.
Publicado: (2002)

Influence of Life Style Factors on Barrett's Oesophagus
por: Horna Strand, A., et al.
Publicado: (2014)

Oesophageal xanthalasma with Barrett’s Oesophagus and Menetrier’s Disease
por: Mason, A, et al.
Publicado: (2011)

Genetic progression of Barrett's oesophagus to oesophageal adenocarcinoma
por: Gregson, Eleanor M, et al.
Publicado: (2016)

Extrachromosomal DNA in the cancerous transformation of Barrett’s oesophagus
por: Luebeck, Jens, et al.
Publicado: (2023)

HER-2/neu oncogene: what does amplification mean?
por: Pavy, J. J., et al.
Publicado: (1993)

Role of body composition and metabolic profile in Barrett’s oesophagus and progression to cancer
por: Di Caro, Simona, et al.
Publicado: (2016)

Chronic constipation: no more idiopathic, but a true neuropathological entity
por: Bassotti, Gabrio, et al.
Publicado: (2011)

Quality of life measures in dysplastic Barrett’s oesophagus are comparable to patients with non-dysplastic Barrett’s oesophagus and do not improve after endoscopic therapy
por: Ratcliffe, Elizabeth, et al.
Publicado: (2023)

Evaluation of C-ErbB-2 Overexpression and Her-2/neu Gene Copy Number Heterogeneity in Barrett’s Adenocarcinoma
por: Walch, Axel, et al.
Publicado: (2000)

Coding of Barrett’s oesophagus with high-grade dysplasia in national administrative databases: a population-based cohort study
por: Chadwick, Georgina, et al.
Publicado: (2017)

Mutational load may predict risk of progression in patients with Barrett’s oesophagus and indefinite for dysplasia: a pilot study
por: Trindade, Arvind J, et al.
Publicado: (2019)

Volumetric laser endomicroscopy features of dysplasia at the gastric cardia in Barrett’s oesophagus: results from an observational cohort study
por: Trindade, Arvind J, et al.
Publicado: (2019)

Differential SPARC mRNA expression in Barrett's oesophagus
por: Brabender, J, et al.
Publicado: (2003)

HER-2/neu and E-cadherin Expression and Microsatellite Instability in Gastric Dysplasia
por: Ahmadi, L, et al.
Publicado: (2011)

Does laparoscopic Nissen fundoplication prevent the progression of Barrett’s oesophagus? Is the length of Barrett’s a factor?
por: Bamehriz, Fahad, et al.
Publicado: (2005)

Barrett’s oesophagus: Is there a need for laparoscopic anti-reflux surgery?
por: Sarela, Abeezar I.
Publicado: (2005)

MIC-1/GDF15 in Barrett's oesophagus and oesophageal adenocarcinoma
por: Fisher, O M, et al.
Publicado: (2015)

The Role of Quantitative Pathology in Clinical Decision Making for Barrett’s Oesophagus
por: Polkowski, Wojciech, et al.
Publicado: (2003)

Dynamic clonal equilibrium and predetermined cancer risk in Barrett's oesophagus
por: Martinez, Pierre, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_65kjd2seljev59bf7dqeoh2pa1